Posted in Web AstraZeneca’s Combination Inhaler Shines In Phase 3 Asthma Trial – Benzinga June 9, 2022 AstraZeneca Plc AZN posted full results from the positive MANDALA Phase 3 trial of PT027, an albuterol/budesonide fixed-dose combination rescue medication in patients with asthma. https://www.benzinga.com/general/biotech/22/05/27228402/astrazenecas-combination-inhaler-shines-in-phase-3-asthma-trial